| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:30–8:30 AM | Breakfast |
| 8:00–8:30 AM | Poster Setup |
| 8:15–5:00 PM | Poster Viewing |
| 8:30–8:40 AM | Welcome Remarks |
| 8:40–9:30 AM | Keynote Address |
| Halidou Tinto †, Institute of Research in Health Sciences, IRSS, Malaria Vaccines Past, Present and Future |
| 9:30–11:45 AM | Malaria Vaccines I: Multi-Stage and Sporozoite Vaccines |
| Angela Minassian, University of Oxford R21 and Rh5 Vaccines |
| Issaka Sagara †, Malaria Research and Training Center R21 and Pfs230 Vaccines |
| Ana Paula Fernandes †, Universidade Federal de Minas Gerais Pv CSP Vaccines |
| Meta Roestenberg †, Leiden University Medical Center LARP SPZ Vaccines |
| Short Talk(s) Chosen from Abstracts |
| 10:00–10:20 AM | Coffee Break |
| 11:45–12:45 PM | Lunch |
| 12:30–2:30 PM | Posters |
| 2:30–4:30 PM | Symposia Spotlight 1: Natural Immunity Against Malaria and Impact on Vaccines |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Malaria Vaccines II: Next-Generation Structure-Based Vaccines |
| Robert A. Seder, NIAID, National Institutes of Health CSP Nanoparticle Vaccines |
| Jordan R Barrett †, The Scripps Research Institute Blood-Stage Vaccine Design |
| Jean-Philippe Julien †, Hospital for Sick Children Research Institute Multi-Stage Vaccine Design |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | On Own for Dinner |
| 7:30–8:30 AM | Breakfast |
| 8:00–8:30 AM | Poster Setup |
| 8:15–5:00 PM | Poster Viewing |
| 8:30–11:30 AM | Humoral and Cellular Immune Responses Following Vaccination and Natural Infection |
| Carlota Dobaño †, ISGlobal Effect of Antibodies on Vaccine Elicited Responses |
| Jake Baum †, University of New South Wales Sydney Cellular Responses Post Whole Parasite Vaccination |
| Marcelle Van Mechelen †, Vaccine Formulation Institute Human Immune Responses to New Adjuvants |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:30–12:30 PM | Lunch |
| 12:30–2:30 PM | Posters |
| 3:00–4:30 PM | Career Roundtable |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Complementary Tools to Vaccines: Long-Acting Drugs and Monoclonal Antibodies |
| Kassoum Kayentao †, University of Bamako Monoclonal Antibody Trials |
| Joshua Hoong Yu Tan †, NIAID, National Institutes of Health High Throughput Antibody Discovery Approaches |
| Arnab Chatterjee †, Calibr at Scripps Research Long-Acting Injectable Atovaquone and Injectocide Ivermectin |
| David B. Olsen †, Merck and Co. Long-Acting Small Molecules to Enhance Pre-Erythrocytic Immunity |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | On Own for Dinner |
| 7:30–8:30 AM | Breakfast |
| 8:30–11:30 AM | Parasite Evolution Following Vaccination and Infection |
| Daniel Neafsey †, Harvard TH Chan School of Public Health Sequencing Following CSP Vaccines |
| Laty Thiam †, Institut Pasteur de Dakar Sequencing of Blood-Stage Infection |
| Ellen Knuepfer †, Royal Veterinary College PCR Complex in P vivax and P knowlesi |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:40–12:40 PM | Panel Discussion: Translational Hurdles, Regulatory Challenges, and Lessons Learned from Clinical Trials |
| 12:40–1:40 PM | Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: Durability of Humoral and Cellular Immunity Following Vaccination |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–6:45 PM | Malaria Elimination: Tools, Strategies, and Implementation |
| Katharine A. Collins †, Coefficient Giving Development of Multi-Stage Vaccines |
| Josephine Malinga †, Kids Research Institute Australia Modelling of Multistage Vaccines |
| Simon K. Kariuki, Kenya Medical Research Institute Implementation of Vaccines |
| Short Talk(s) Chosen from Abstracts |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions |
| 7:00–8:00 PM | On Own for Dinner |
| 12:00–11:59 PM | Departure |